Location: Home
  • search
  • go
  • Relate News
  • 5/9/2024BIO Survey Shows 79% of US biotech Cos Contract with Chinese Firms
  • 5/8/2024China Makes Progress in Enhancing Primary Healthcare Services
  • 5/8/2024NHC Issues New Guidelines to Improve Critical Care Medical Services
  • 5/8/2024China Moves to Improve Healthcare Experience of Patients: NHC
  • 5/7/2024China's New Guidelines Boost Critical Care Services
  • 5/7/2024Recent Executive Moves
  • 5/7/2024Review of Leading Listed Chinese Pharma Cos by R&D Spending in 2023
  • 5/7/2024Sanofi Saw 6.2% China Revenue Growth in Q1/2024 on Strong Drug Sales
  • 5/7/2024Chinese President Promises to Further Open China's Services Sector Inc...
  • 5/1/2024Snapshot of BMI System Financial Performance in Q1/2024
  • 5/1/2024PTAB to Hold Trial in Patent Dispute Involving BeiGene and AbbVie's Ph...
  • 5/1/2024BIO Survey Investigates US Biopharma's Dependence on Chinese CDMOs Ami...
  • 5/1/2024Biotech Giants, Lawyers Warn of 'Dramatic Impact' (Asian Legal Busines...
  • 4/30/2024Sino Biological Concludes Acquisition of Canada's SignalChem Biotech f...
  • 4/29/2024China to Conduct Restrospective Inspection of Healthcare Institutions ...
  • 4/29/2024WuXi Wants to Regain Client Confidence Amid Claims of IP Transfer to C...
  • 4/29/2024A US-China Pharma Drug War in the Making (Asia Times)
  • 4/29/2024Key Considerations for Entering China's Healthcare Market
  • 4/26/2024BMS and Cellares Collaboration: Navigating U.S.-China Biopharma Tensio...
  • 4/26/2024China to Further Strengthen Community Medical Services
  • 4/26/2024Recent Executive Moves
  • 4/24/2024NHC Issues Announcement on Jurisdiction of Human Genetic Resource Mana...
  • 4/24/2024Review of Leading Class 1 New Drugs by Chinese Sales Value in 2023
  • 4/23/2024Free Pricing in China for Highly Innovative Medicines (LinkedIn)
  • 4/19/2024How BIO CEO's Cozy Relationship with WuXi Soured (STAT)
  • 4/19/2024Recent Executive Moves
  • 4/17/2024China Announces the 2024 Special Rectification Plan for Illegal Activi...
  • 4/16/2024America Hits Chinese Biotech — And Its Own Drugmakers (Economist)
  • 4/15/2024China Biopharma Tracker – Q1 2024 (PharmaDJ)
  • 4/15/2024The Pharmaceutical Playbook for Asia’s Private Market (PharmExec)
  • Page:6/333 Total number of articles:9986: [First][<<] [4] [5] [6] [7] [8] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group